Zai Lab Stock Has Fallen to Value Levels

by Jea Yu • June 24, 2022 • 0 Comments

Commercial stage global biotech company Zai Lab (NASDAQ: ZLAB) stock has cratered (-82%) from a 52-week high of $178.91.